Core B: Developmental core

核心B:发展核心

基本信息

  • 批准号:
    10090663
  • 负责人:
  • 金额:
    $ 43.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-03 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

CORE B: Abstract/Summary The Developmental Core (Core B) supports the overall mission of the PMHARC through its services focused on training, mentoring, and management of the pilot projects program. During the current funding cycle, Core B, in partnership with the Administrative Core and the PMHARC Executive Committee (EC) established a rigorous, efficient strategy for the solicitation and review of high priority pilot research focused on mental illness and HIV/AIDS. The role of the pilot projects program within the PMHARC is central to its overall mission and provides the framework for the delivery of much of the Center's training and mentoring services. Pilots are expected to pair experienced investigators with early career or transitional investigators. All Cores are expected to assist with the development of pilot concepts and proposals and if selected for funding, provide services to the pilot investigators and their projects at no cost, adding real value to each pilot. During this first funding cycle, the PMHARC invested 10% of its annual total costs to support pilot projects and a total of 26 projects have been funded thus far with support of up to $40,000 each. In all of the Core's services, priority is given to early career investigators and investigators from underrepresented racial and ethnic groups. Forty-four early career and transitioning investigators have been engaged in pilot projects thus far, 21% are from racial and ethnic minority groups and 61% are women. To assist with the recruitment of participants for the pilot projects, the Core established the bi-weekly recruitment support group. As a result of the success of this group in assisting with recruitment for HIV/AIDS research beyond the pilots, this service transitioned to become an ongoing service of the Community Engagement Core. During the current funding cycle, the Developmental Core established the monthly PMHARC Journal Club that provides a forum for presentation and discussion of significant research focused on mental illness and HIV/AIDS. The Journal Club is also used as a venue for pilot investigators to present findings, receive feedback on interpretation of data, plan for publication and subsequent grant submissions, and practice presentation skills. Core B also led the development and implementation of the first city-wide conference designed to increase awareness of HIV research taking place in Philadelphia and to promote research collaborations. The serves as a clearinghouse for related seminars and trainings offered both on and off campus. During the next funding cycle, we will build on the success of the pilot projects program by working with seven other centers and institutes on campus to co-sponsor pilot projects, expanding the scientific reach of the PMHARC and providing increased funds for larger projects. As more pilots are completed, there will be an increased opportunity to promote publication of findings and grant applications. The Core will continue to facilitate mentoring relationships and collaborations and provide ongoing monitoring and evaluation of the pilot projects program.
核心 B:摘要/总结 发展核心(核心 B)通过其重点服务支持 PMHARC 的总体使命 试点项目计划的培训、指导和管理。在当前的融资周期内,核心 B、与行政核心和 PMHARC 执行委员会 (EC) 合作建立了 针对精神疾病的高优先级试点研究征集和审查的严格、有效的策略 和艾滋病毒/艾滋病。 PMHARC 中试点项目计划的作用是其总体使命的核心, 为提供中心的大部分培训和指导服务提供了框架。飞行员是 预计将经验丰富的调查员与早期职业或过渡性调查员配对。所有核心都是 预计将协助制定试点概念和提案,如果选择资助,则提供 免费为试点研究人员及其项目提供服务,为每个试点增加真正的价值。在这第一 资助周期中,PMHARC 投入其年度总成本的 10% 来支持试点项目,共计 26 个 迄今为止,每个项目已获得高达 40,000 美元的资助。在所有核心服务中,优先级是 给予早期职业调查员和来自代表性不足的种族和族裔群体的调查员。四十四 迄今为止,早期职业和转型调查员已参与试点项目,其中 21% 来自种族 和少数族裔群体,其中 61% 是女性。协助招募试点参与者 项目期间,核心建立了每两周一次的招聘支持小组。由于这个团体的成功 为了协助招募试点以外的艾滋病毒/艾滋病研究人员,这项服务转变为一项服务 社区参与核心的持续服务。在当前的资助周期内,发展 Core 建立了每月一次的 PMHARC Journal Club,为展示和讨论以下内容提供了一个论坛: 重要的研究集中在精神疾病和艾滋病毒/艾滋病上。期刊俱乐部也被用作飞行员的场地 研究人员提出调查结果,接收有关数据解释的反馈,出版计划和 随后提交拨款,并练习演讲技巧。 Core B 还领导了开发和 举办第一次全市范围的会议,旨在提高人们对艾滋病毒研究的认识 费城并促进研究合作。作为相关研讨会的信息交换所 以及校内和校外提供的培训。在下一个融资周期中,我们将在成功的基础上再接再厉 与校园内其他七个中心和机构合作共同发起试点项目 项目,扩大 PMHARC 的科学范围,并为更大的项目提供更多的资金。作为 更多试点完成后,将有更多机会促进调查结果的发布和拨款 应用程序。核心将继续促进指导关系和合作,并提供 持续监测和评估试点项目计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID S METZGER其他文献

DAVID S METZGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID S METZGER', 18)}}的其他基金

Administrative Core A
行政核心A
  • 批准号:
    10891051
  • 财政年份:
    2023
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10436808
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10197865
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10654008
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
mu-阿片受体结合对 HIV 感染者、ART 抑制的阿片类药物使用障碍患者微生物易位和残余免疫激活的影响,开始药物辅助治疗
  • 批准号:
    10004224
  • 财政年份:
    2019
  • 资助金额:
    $ 43.91万
  • 项目类别:
Rapid initiation of buprenorphine/naloxone to optimize MAT utilization in Philadelphia
快速启动丁丙诺啡/纳洛酮以优化费城 MAT 的利用
  • 批准号:
    9896726
  • 财政年份:
    2018
  • 资助金额:
    $ 43.91万
  • 项目类别:
Behavioral & Social Sciences
行为的
  • 批准号:
    7684973
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    8261981
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    7687184
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:
Efficacy of Drug-HIV counseling among IDU at Methadone clinics in Jakarta
雅加达美沙酮诊所注射吸毒者药物艾滋病毒咨询的效果
  • 批准号:
    8085908
  • 财政年份:
    2009
  • 资助金额:
    $ 43.91万
  • 项目类别:

相似海外基金

Scientific Leadership Group Core
科学领导小组核心
  • 批准号:
    10595900
  • 财政年份:
    2023
  • 资助金额:
    $ 43.91万
  • 项目类别:
A randomized controlled pilot study to examine the impact of a filmed dramatized story intervention (telenovela/soap opera) for HIV prevention in Latinas
一项随机对照试点研究,旨在检验电影化故事干预(电视剧/肥皂剧)对拉丁裔艾滋病毒预防的影响
  • 批准号:
    10403030
  • 财政年份:
    2022
  • 资助金额:
    $ 43.91万
  • 项目类别:
Johns Hopkins University Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
约翰·霍普金斯大学站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
  • 批准号:
    10599562
  • 财政年份:
    2022
  • 资助金额:
    $ 43.91万
  • 项目类别:
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
SARS-CoV-2 抗病毒核糖核苷类似物对线粒体 DNA 的影响
  • 批准号:
    10448062
  • 财政年份:
    2022
  • 资助金额:
    $ 43.91万
  • 项目类别:
Leveraging A Low-Intensity Behavioral Intervention for HIV Care to Target Depressive Symptoms in People Living with HIV
利用低强度行为干预进行艾滋病毒护理,以针对艾滋病毒感染者的抑郁症状
  • 批准号:
    10764605
  • 财政年份:
    2022
  • 资助金额:
    $ 43.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了